Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Wall Street
Price Targets
ARWR Price Targets Summary
Arrowhead Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ARWR
is 56.49 USD
with a low forecast of 28.28 USD and a high forecast of 94.5 USD.
ARWR Last Price Targets
Arrowhead Pharmaceuticals Inc
The latest public price target was made on Feb 7, 2023 by
Unknown Analyst
from
RBC Capital
,
who expects
ARWR
stock to
rise by 248%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Unknown Analyst
RBC Capital
|
77
USD
Upside 248% |
1 year ago
Feb 7, 2023
|
RBC Capital Maintains Outperform on Arrowhead Pharma, Lowers Price Target to $77
Benzinga
|
Unknown Analyst
Piper Sandler
|
52
USD
Upside 135% |
1 year ago
Feb 7, 2023
|
Piper Sandler Maintains Overweight on Arrowhead Pharma, Lowers Price Target to $52
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARWR's stock price target?
Price Target
56.49
USD
According to Wall Street analysts, the average 1-year price target for
ARWR
is 56.49 USD
with a low forecast of 28.28 USD and a high forecast of 94.5 USD.
What is Arrowhead Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Arrowhead Pharmaceuticals Inc's revenue is
123%.
The projected
CAGR
for the next 3 years is
6%.
You don't have any saved screeners yet
